About

Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally. Flerie is based in Stockholm and London managing a portfolio of over 30 investments in Europe, Israel, and the US. We enable companies that are built on pioneering science to succeed by providing them with resources and expertise. We have over SEK 3,000 million Asset Under Management (AUM) spread across three segments; Product Development, Commercial Growth and Limited Partnerships.

People

We invest in passionate entrepreneurs with an ambition to impact the industry, who have an experienced team backed by academia and science.

Setting

We primarily invest in private companies. In addition, we invest selectively in public companies, and investment funds as a limited partner.

Sectors

We invest predominantly in the drug development field, including related devices and services. This includes modalities such as cell and gene therapy, vaccines, biologics and small molecules.

Horizon

Our evergreen structure allows long-term value creation in the portfolio. We invest off our own balance sheet and recycle the investment pool. We aim to be invested as long as we will contribute and build value.

Stage

Investments in the product development segment cover companies from formation and pre-clinical stage to clinical phase I/II/III. Investments in the commercial growth segment cover companies from early revenue-generation towards profitability.